Bringing genome-wide association findings into clinical use (original) (raw)

• Lango Allen, H. et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467, 832–838 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747–753 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Goldstein, D. B. Common genetic variation and human traits. N. Engl. J. Med. 360, 1696–1698 (2009).
  Article CAS PubMed Google Scholar
• Jakobsdottir, J., Gorin, M. B., Conley, Y. P., Ferrell, R. E. & Weeks, D. E. Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. PLoS Genet. 5, e1000337 (2009). This is a review of the predictive ability of strongly associated GWAS-defined SNPs in four diseases, demonstrating that high odds ratios (>50) are needed to improve prediction.
  Article CAS PubMed PubMed Central Google Scholar
• Aschard, H. et al. Inclusion of gene–gene and gene–environment interactions unlikely to dramatically improve risk prediction for complex diseases. Am. J. Hum. Genet. 90, 962–972 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Manolio, T. A. Genome-wide association studies and disease risk assessment. N. Engl. J. Med. 363, 166–176 (2010).
  Article CAS PubMed Google Scholar
• Lopes, M. C., Zeggini, E. & Panoutsopoulou, K. Do genome-wide association scans have potential for translation? Clin. Chem. Lab. Med. 50, 255–260 (2011).
  PubMed Google Scholar
• Evans, J. P., Meslin, E. M., Marteau, T. M. & Caulfield, T. Deflating the genomic bubble. Science 331, 861–862 (2011).
  Article CAS PubMed Google Scholar
• Varmus, H. Ten years on — the human genome and medicine. N. Engl. J. Med. 362, 2028–2029 (2010).
  Article CAS PubMed Google Scholar
• Dulbecco, R. A turning point in cancer research: sequencing the human genome. Science 231, 1055–1056 (1986).
  Article CAS PubMed Google Scholar
• Collins, F. Shattuck lecture: medical and societal consequences of the human genome project. N. Engl. J. Med. 341, 28–37 (1999).
  Article CAS PubMed Google Scholar
• Committee on Quality of Health Care in America, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century (National Academy Press, 2001).
• Klein, R. J. et al. Complement factor H polymorphism in age-related macular degeneration. Science 308, 385–389 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Rioux, J. D. et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nature Genet. 39, 596–604 (2007).
  Article CAS PubMed Google Scholar
• Budarf, M. L., Labbé, C., David, G. & Rioux, J. D. GWA studies: rewriting the story of IBD. Trends Genet. 25, 137–146 (2009).
  Article CAS PubMed Google Scholar
• Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061–1073 (2010).
• Tennessen, J. A. et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337, 64–69 (2012). This is a summary report of rare variation identified in the US National Institutes of Health (NIH) Heart, Lung and Blood Institute Exome Sequencing Project for 15,585 human protein-coding genes in 2,440 individuals of European and African ancestry.
  Article CAS PubMed PubMed Central Google Scholar
• McClellan, J. & King, M. C. Genetic heterogeneity in human disease. Cell 141, 210–217 (2010).
  Article CAS PubMed Google Scholar
• Bustamante, C. D., Burchard, E. G. & de la Vega, F. M. Genomics for the world. Nature 475, 163–165 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Spencer, C., Hechter, E., Vukcevic, D. & Donnelly, P. Quantifying the underestimation of relative risks from genome-wide association studies. PLoS Genet. 7, e1001337 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Cirulli, E. T. & Goldstein, D. B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nature Rev. Genet. 11, 415–425 (2010).
  Article CAS PubMed Google Scholar
• Maher, B. Personal genomes: the case of the missing heritability. Nature 456, 18–21 (2008).
  Article CAS PubMed Google Scholar
• Tuzun, E. et al. Fine-scale structural variation of the human genome. Nature Genet. 37, 727–732 (2005).
  Article CAS PubMed Google Scholar
• McCarroll, S. A. Extending genome-wide association studies to copy-number variation. Hum. Mol. Genet. 17, R135–R142 (2008).
  Article CAS PubMed Google Scholar
• Chung, C. C. & Chanock, S. J. Current status of genome-wide association studies in cancer. Hum. Genet. 130, 59–78 (2011).
  Article PubMed Google Scholar
• Travers, M. E. & McCarthy, M. I. Type 2 diabetes and obesity: genomics and the clinic. Hum. Genet. 130, 41–58 (2011).
  Article CAS PubMed Google Scholar
• Mohlke, K. L. & Scott, L. J. What will diabetes genomes tell us? Curr. Diab. Rep. 12, 643–650 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Servin, B. & Stephens, M. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet. 3, e114 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Hindorff, L. A. et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA 106, 9362–9367 (2009). An overview of functional annotations for GWAS-defined SNPs in the first 3 years of experience is presented here, and it demonstrates that a high proportion (>80%) of associations fall in non-coding regions.
  Article PubMed PubMed Central Google Scholar
• Girirajan, S. et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N. Engl. J. Med. 367, 1321–1331 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• He, Y., Hoskins, J. M. & McLeod, H. L. Copy number variants in pharmacogenetic genes. Trends Mol. Med. 17, 244–251 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ernst, J. et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473, 43–49 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012). This is the lead paper of 30 coordinated papers describing ENCODE findings of functional DNA sequences related to transcription, transcription factor association, chromatin structure and histone modification.
• Moffatt, M. F. et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448, 470–473 (2007).
  Article CAS PubMed Google Scholar
• Zhang, Y., Moffatt, M. F. & Cookson, W. O. Genetic and genomic approaches to asthma: new insights for the origins. Curr. Opin. Pulm. Med. 18, 6–13 (2012).
  Article CAS PubMed Google Scholar
• Ober, C. & Yao, T. C. The genetics of asthma and allergic disease: a 21st century perspective. Immunol. Rev. 242, 10–30 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461–1463 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Sarin, R., Wu, X. & Abraham, C. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc. Natl Acad. Sci. USA 108, 9560–9565 (2011).
  Article PubMed PubMed Central Google Scholar
• Craig, D. W. et al. Assessing and managing risk when sharing aggregate genetic variant data. Nature Rev. Genet. 12, 730–736 (2011).
  Article CAS PubMed Google Scholar
• Kraft, P. et al. Beyond odds ratios — communicating disease risk based on genetic profiles. Nature Rev. Genet. 10, 264–269 (2009).
  Article CAS PubMed Google Scholar
• Cornelis, M. C. et al. Joint effects of common genetic variants on the risk for type 2 diabetes in U.S. men and women of European ancestry. Ann. Intern. Med. 150, 541–550 (2009).
  Article PubMed PubMed Central Google Scholar
• van der Net, J. B., Janssens, A. C., Sijbrands, E. J. & Steyerberg, E. W. Value of genetic profiling for the prediction of coronary heart disease. Am. Heart J. 158, 105–110 (2009).
  Article PubMed Google Scholar
• Ware J. H. The limitations of risk factors as prognostic tools. N. Engl. J. Med. 355, 2615–2617 (2006).
  Article CAS PubMed Google Scholar
• Kraft, P. & Hunter, D. J. Genetic risk prediction—are we there yet? N. Engl. J. Med. 360, 1701–1703 (2009).
  Article CAS PubMed Google Scholar
• Wray, N. R., Goddard, M. E. & Visscher, P. M. Prediction of individual genetic risk of complex disease. Curr. Opin. Genet. Dev. 18, 257–263 (2008).
  Article CAS PubMed Google Scholar
• Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am. J. Hum. Genet. 40, 1–14 (1987).
  CAS PubMed PubMed Central Google Scholar
• Polychronakos, C. & Li, Q. Understanding type 1 diabetes through genetics: advances and prospects. Nature Rev. Genet. 12, 781–792 (2011). This is a Review of allelic architecture of genetic susceptibility to type 1 diabetes, based on GWASs, fine mapping and functional studies, and the potential for genetic prediction of T1D risk.
  Article CAS PubMed Google Scholar
• Chatenoud, L., Warncke, K. & Ziegler, A. G. Clinical immunologic interventions for the treatment of type 1 diabetes. Cold Spring Harb. Perspect. Med. 2, a007716 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Bradfield, J. P. et al. A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genet. 7, e1002293 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Jostins, L. & Barrett, J. C. Genetic risk prediction in complex disease. Hum. Mol. Genet. 20, R182–R188 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Clayton, D. G. Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet. 5, e1000540 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Bingley, P. J. Clinical applications of diabetes antibody testing. J. Clin. Endocrinol. Metab. 95, 25–33 (2010).
  Article CAS PubMed Google Scholar
• Gallagher, M. P., Goland, R. S. & Greenbaum, C. J. Making progress: preserving β cells in type 1 diabetes. Ann. NY Acad. Sci. 1234, 119–134 (2011).
  Article Google Scholar
• Dunlop, M. G. et al. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals. Gut 62, 871–881 (2013).
  Article CAS PubMed Google Scholar
• Kathiresan, S. et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N. Engl. J. Med. 358, 1240–1249 (2008).
  Article CAS PubMed Google Scholar
• Shields, B. M. et al. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53, 2504–2508 (2010).
  Article CAS PubMed Google Scholar
• Shepherd, M. et al. Predictive genetic testing in maturity-onset diabetes of the young (MODY). Diabet Med. 18, 417–421 (2001).
  Article CAS PubMed Google Scholar
• Owen, K. R. et al. Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations. Diabetes Care 33, 1919–1924 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Reiner, A. P. et al. Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 α are associated with C-reactive protein. Am. J. Hum. Genet. 82, 1193–1201 (2008). One of two initial GWASs demonstrating association between HNF1A and C-reactive protein levels is presented here.
  Article CAS PubMed PubMed Central Google Scholar
• Toniatti, C., Demartis, A., Monaci, P., Nicosia, A. & Ciliberto, G. Synergistic _trans_-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites. EMBO J. 9, 4467–4475 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Thanabalasingham, G. et al. A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia 54, 2801–2810 (2011).
  Article CAS PubMed Google Scholar
• Fellay, J. et al. ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. Nature 464, 405–408 (2010). This is the first GWAS to demonstrate association between ITPA and ribavirin-induced anaemia.
  Article CAS PubMed Google Scholar
• Asselah, T., Pasmant, E. & Lyoumi, S. Unraveling the genetic predisposition of ribavirin-induced anaemia. J. Hepatol. 53, 971–973 (2010).
  Article CAS PubMed Google Scholar
• Thompson, A. J. et al. Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction. Gastroenterology 139, 1181–1189 (2010).
  Article CAS PubMed Google Scholar
• Hitomi, Y. et al. Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function. Gastroenterology. 140, 1314–1321 (2011). This functional study demonstrates that ITP substitutes for GTP for use by human adenylosuccinate synthase, thereby bypassing the ribavirin-induced depletion of GTP and subsequent haemolysis.
  Article CAS PubMed Google Scholar
• Carroll, M. D., Kit, B. K., Lacher, D. A., Shero, S. T. & Mussolino, M. E. Trends in lipids and lipoproteins in US adults, 1988–2010. JAMA 308, 1545–1554 (2012).
  Article CAS PubMed Google Scholar
• Thompson, P. D., Clarkson, P. & Karas, R. H. Statin-associated myopathy. JAMA 289, 1681–1690 (2003).
  Article CAS PubMed Google Scholar
• Wilke, R. A. et al. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. Clin. Pharmacol. Ther. 92, 112–117 (2010). This is a review of the impact of SLCO1B1 variants on patient response to statins and consensus guidelines for reducing the risk of simvastatin myopathy in variant carriers.
  Article CAS Google Scholar
• Mammen, A. L. & Amato, A. A. Statin myopathy: a review of recent progress. Curr. Opin. Rheumatol. 22, 644–650 (2010).
  Article CAS PubMed Google Scholar
• SEARCH Collaborative Group. SLCO1B1 variants and statin-induced myopathy—a genomewide study. N. Engl. J. Med. 359, 789–799 (2008).
• Ghatak, A., Faheem, O. & Thompson, P. D. The genetics of statin-induced myopathy. Atherosclerosis 210, 337–343 (2010).
  Article CAS PubMed Google Scholar
• Niemi, M., Pasanen, M. K. & Neuvonen, P. J. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol. Rev. 63, 157–181 (2011).
  Article CAS PubMed Google Scholar
• Voora, D. et al. The SLCO1B1*5 genetic variant is associated with statin-induced side effects. J. Am. Coll. Cardiol 54, 1609–1616 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Maggo, S. D., Kennedy, M. A. & Clark, D. W. Clinical implications of pharmacogenetic variation on the effects of statins. Drug Saf. 34, 1–19 (2011).
  Article CAS PubMed Google Scholar
• Treviño, L. R. et al. Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J. Clin. Oncol. 27, 5972–5978 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ramsey, L. B. et al. Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. Genome Res. 22, 1–8 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Johnson, A. D. et al. Genome-wide association meta-analysis for total serum bilirubin levels. Hum. Mol. Genet. 18, 2700–2710 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kerns, S. L. et al. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 85, e21–e28 (2013).
  Article CAS PubMed Google Scholar
• Malhotra, A. K. et al. Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. Arch. Gen. Psych. 69, 904–912 (2012).
  Article CAS Google Scholar
• Comen, E. et al. Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women. Breast Cancer Res. Treat. 127, 479–487 (2011).
  Article CAS PubMed Google Scholar
• Nguyen, T. V. & Eisman, J. A. Genetics and the individualized prediction of fracture. Curr. Osteoporos Rep. 10, 236–244 (2012).
  Article PubMed Google Scholar
• Knowles, J. W. et al. Randomized trial of personal genomics for preventive cardiology: design and challenges. Circ. Cardiovasc. Genet. 5, 368–376 (2012).
  Article PubMed PubMed Central Google Scholar
• Kao, W. H. et al. Family investigation of nephropathy and diabetes research group. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nature Genet. 40, 1185–1192 (2008).
  Article CAS PubMed Google Scholar
• Tzur, S. et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum. Genet. 128, 345–350 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Guedj, M. et al. A refined molecular taxonomy of breast cancer. Oncogene 31, 1196–1206 (2012).
  Article CAS PubMed Google Scholar
• Nevins, J. R. Pathway-based classification of lung cancer: a strategy to guide therapeutic selection. Proc. Am. Thorac Soc. 8, 180–182 (2011).
  Article PubMed PubMed Central Google Scholar
• Vermeire, S. Towards a novel molecular classification of IBD. Dig. Dis. 30, 425–427 (2012).
  Article PubMed Google Scholar
• Troutbeck, R., Al-Qureshi, S. & Guymer, R. H. Therapeutic targeting of the complement system in age-related macular degeneration: a review. Clin. Experiment Ophthalmol. 40, 18–26 (2012).
  Article PubMed Google Scholar
• Baldwin, R. M. et al. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin. Cancer Res. 18, 5099–5109 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Park, B. L. et al. Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. Hum. Genet. 132, 313–321 (2013).
  Article CAS PubMed Google Scholar
• Manolio, T. A. et al. Implementing genomic medicine in the clinic: the future is here. Genet. Med. 15, 258–267 (2013). This is a description of actively implemented genomic medicine programs at multiple US institutions, including common challenges, infrastructure and research needs. It outlines an implementation framework for investigating and introducing similar programmes elsewhere.
  Article PubMed PubMed Central Google Scholar
• Crews, K. R., Hicks, J. K., Pui, C. H., Relling, M. V. & Evans, W. E. Pharmacogenomics and individualized medicine: translating science into practice. Clin. Pharmacol. Ther. 92, 467–475 (2012).
  CAS PubMed Google Scholar
• Manolio, T. A. & Green, E. D. Genomics reaches the clinic: from basic discoveries to clinical impact. Cell 147, 14–16 (2011).
  Article CAS PubMed Google Scholar